⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockFranceNasdaqGS

NBTX

Nanobiotix S.A.

Healthcare · Biotechnology

29.36USD

+0.1700 (+0.58%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on NBTX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End12/2025 Q4
Current/T12M(EUR)
1)

Issue Data

Last PxUSD / 29.36
P/E—
Dvd Ind Yld0.0%
P/B—
P/S50.5
Curr EV/T12M EBITDA—
Mkt Cap (USD)1.5B
Curr EV (USD)—
2)

Per Share Data

EPS T12M-0.50
DPS—
Bk Val Per Sh-0.74
Rev/Sh0.62
Cash/Sh2.18
Curr Shares Out50.9M
FCF/Sh-0.71
3)

Cash Flow Analysis

P/CF-44.8
Curr P/FCF-44.0
CF/NI1.4
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-112.7%
Eff Interest Rate14.9%
4)

Growth Potential

Dil EPS 1Y Gr65.3%
Cap 1Y Gr140.7%
BPS 1Y Gr-27.1%
R&D To Sales78.0%
Retention Rate—
Rev 1Y Gr355.3%
FCF 1Y Gr-66.5%
Assets 1Y Gr0.5%
5)

Profitability

EBITDA-0.0B
EBIT-0.0B
Operating Margin-36.5%
Pretax Margin-80.8%
Net Margin-80.8%
ROA-37.6%
ROE43.0%
ROC—
Asset Turnover0.46
6)

Structure

Current Ratio1.09
Quick Ratio1.40
Debt/Assets136.1%
Debt/Com Eq-109.2%
Net Debt/EBITDA-4.23
Tot Debt/Capital1191.9%
Gross Margin100.0%
EBIT/Int Exp-1.0

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years. This company reports in a different currency from the one its shares trade in, so any ratio dividing a market value by a statement figure crosses that boundary un-converted.